| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8734626 | Revista Brasileira de Hematologia e Hemoterapia | 2017 | 7 Pages |
Abstract
Everolimus was found to provide a response in a group of patients with refractory or relapsed Hodgkin's lymphoma who had adequate tolerability to the drug.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Talita Máira Bueno da Silveira da Rocha, Sergio Costa Fortier, Thais Rodrigues da Cunha Fischer, Guilherme Fleury Perini, Rafael Dezen Gaiolla, Laura Fogliatto, Marcia Torresan Delamain, Andressa Fragoso da Costa, Nelson Siqueira de Castro,